Navana Pharmaceuticals PLC Sustainability Profile
Navana Pharmaceuticals PLC, a prominent player in the pharmaceutical industry, is headquartered in Bangladesh (BD) and has established a significant presence across various operational regions. Founded in 1992, the company has achieved notable milestones, including the development of a diverse portfolio of high-quality generic and branded medications. Specialising in therapeutic areas such as cardiology, diabetes, and infectious diseases, Navana Pharmaceuticals is recognised for its commitment to innovation and quality. Their core products, which include a range of formulations and dosage forms, are distinguished by rigorous adherence to international standards and regulatory compliance. With a strong market position, Navana Pharmaceuticals has garnered accolades for its contributions to healthcare, making it a trusted name in the industry. The company continues to expand its reach, aiming to enhance patient care both locally and globally.
DitchCarbon Score
How does Navana Pharmaceuticals PLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Navana Pharmaceuticals PLC's score of 23 is lower than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Navana Pharmaceuticals PLC's reported carbon emissions
Navana Pharmaceuticals PLC, headquartered in Bangladesh (BD), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Navana Pharmaceuticals may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. In the context of the pharmaceutical industry, many companies are increasingly adopting science-based targets and sustainability practices to mitigate climate impact. However, without specific emissions data or commitments, it is unclear how Navana Pharmaceuticals aligns with these industry standards. As the company moves forward, establishing measurable climate goals and reporting emissions could enhance its sustainability profile and contribute to broader environmental efforts.
How Carbon Intensive is Navana Pharmaceuticals PLC's Industry?
How Carbon Intensive is Navana Pharmaceuticals PLC's Location?
Navana Pharmaceuticals PLC's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Navana Pharmaceuticals PLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.